Patients in Group 1 ( 126 patients ) received 100mg of CC daily for 5days starting on day 5 of menses , and patients in Group 2 ( 126 patients ) received 100mg of CC daily for 5days starting the next day after finishing medroxyprogesterone acetate ( MPA ) ( before withdrawal bleeding ) .